Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population

Blood (2021) 138 (Supplement 1): 1833.

https://doi.org/10.1182/blood-2021-146532

Published: 2021

Journal Articles

Dynamics of Leukocyte Subpopulations Reconstitution Predict Infection Propensity in a Multiethnic Real World Cohort Treated with Anti-CD19 CAR-T Cell Therapy (Axicabtagene-Ciloleucel)

Astha Thakkar, MBBS, Zhu Cui, MD, Stephen Zachary Peeke, MD, Nishi Shah, MBBS, MPH, Amanda Lombardo, PA-C, BS, MS, Fariha Khatun, PA-C, Jennat Mustafa, PA-C, Alyssa De Castro, PharmD, Kailyn Gillick, PA-C, Felisha Joseph, PA-C, Anjali Naik, PA-C, Shafia Rahman, MD, Angelica D'Aiello, Richard Elkind, PA-C, MS, Susan Sakalian, Karen Fehn, RN, BSN, Karen Wright, RN-BC, MS, OCN, BMTCN, Michelly Abreu, ANP,MSN, Latoya Townsend Nugent, NP, Nicole Chambers, ANP/FNP, Rosmi Mathew, FNP-BC, Donika Binakaj, BBA, Randin Nelson, MD, Carlo Palesi, Monika Paroder, MD, Joan Uehlinger, MD, Yanhua Wang, MD PhD, Yang Shi, MD PhD, Xingxing Zang, PhD, Hao Wang, MS, Christopher Nishimura, BS, Xiaoxin Ren, Ulrich G. Steidl, MDPhD, Kira Gritsman, MDPhD, Murali Janakiram, Noah Kornblum, MD, Olga Derman, MD, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Rachel Bartash, MD, Yoram Puius, MD PhD, Margaret McCort, MD, Mendel Goldfinger, MD, Lizamarie Bachier-Rodriguez, MD, Amit Verma, MBBS, Ira Braunschweig, MD, R. Alejandro Sica, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-139533

Published: 2020

Journal Articles

Common Myeloid Progenitors As Biomarkers of Hbf Response to Hydroxyurea in Sickle Cell Disease

Caterina P. Minniti, MD, Seda S. Tolu, MD, Kai Wang, PhD, Zi Yan, Andrew Crouch, Gracy Sebastian, NP, Mark Chaitowitz, MD, Evan Schwechter, MD, Joan Uehlinger, MD, Deepa Manwani, MD, Eric Fornari, MD, Eric E. Bouhassira, PhD

Blood (2019) 134 (Supplement_1): 4827.

https://doi.org/10.1182/blood-2019-131466

Published: 2019

Journal Articles

Long-Term Hydroxyurea Use Is Associated with Lower Levels of Hematopoietic Stem and Progenitor Cells in Patients with Sickle Cell Disease

Seda S. Tolu, MD, Kai Wang, PhD, Zi Yan, Andrew Crouch, Gracy Sebastian, NP, Mark Chaitowitz, MD, Eric Fornari, MD, Evan Schwechter, MD, Joan Uehlinger, MD, Deepa Manwani, MD, Caterina P. Minniti, MD, Eric E. Bouhassira, PhD

Blood (2019) 134 (Supplement_1): 985.

https://doi.org/10.1182/blood-2019-131648

Published: 2019

Journal Articles

Altered Regulation of Immune Responses in Alloimmunized Chronically Transfused Patients with Sickle Cell Disease.

Weili Bao, MS, Susanne Heck, PhD, Wu He, PhD, Maureen Licursi, MSN,CPNP, Genia Billote, RN, MPH, MFA, Hannah Stephens, RN, Joan Uehlinger, MD, Margaret T. Lee, MD, Sujit Sheth, MD, Karina Yazdanbakhsh, PhD

Blood (2009) 114 (22): 637.

https://doi.org/10.1182/blood.V114.22.637.637

Published: 2009

NARROW

Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population

Dynamics of Leukocyte Subpopulations Reconstitution Predict Infection Propensity in a Multiethnic Real World Cohort Treated with Anti-CD19 CAR-T Cell Therapy (Axicabtagene-Ciloleucel)

Common Myeloid Progenitors As Biomarkers of Hbf Response to Hydroxyurea in Sickle Cell Disease

Long-Term Hydroxyurea Use Is Associated with Lower Levels of Hematopoietic Stem and Progenitor Cells in Patients with Sickle Cell Disease

Altered Regulation of Immune Responses in Alloimmunized Chronically Transfused Patients with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population

Dynamics of Leukocyte Subpopulations Reconstitution Predict Infection Propensity in a Multiethnic Real World Cohort Treated with Anti-CD19 CAR-T Cell Therapy (Axicabtagene-Ciloleucel)

Common Myeloid Progenitors As Biomarkers of Hbf Response to Hydroxyurea in Sickle Cell Disease

Long-Term Hydroxyurea Use Is Associated with Lower Levels of Hematopoietic Stem and Progenitor Cells in Patients with Sickle Cell Disease

Altered Regulation of Immune Responses in Alloimmunized Chronically Transfused Patients with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only